DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 16,640
+1,510 (9.98%)
At close: Feb 27, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 291.48 billion as of February 27, 2026. Its market cap has increased by 62.98% in one year.
Market Cap
291.48B
Enterprise Value
388.82B
Revenue
149.47B
Ranking
n/a
PE Ratio
7,337.11
Stock Price
16,640.00
Market Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 291.48B, an increase of 1,760.31%. That is a compound annual growth rate of 14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 291.48B | -4.53% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 573.02B |
| CellBion | 355.43B |
| NOVAREX | 244.82B |
| OPTUS Pharmaceutical | 207.88B |
| Vivozon Pharmaceutical | 207.12B |
| Organoidsciences | 204.16B |
| GREEN CROSS WellBeing | 182.07B |
| High Tech Pharm | 168.00B |